Memantine Hydrochloride NDC 59651-406

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-406Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0406Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-406-30	59651040630	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-406-30)Marketed from Aug 9, 2021
59651-406-90	59651040690	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-406-90)Marketed from Aug 9, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Memantine Hydrochloride
Generic name (nonproprietary): memantine hydrochloride
Active ingredients: Memantine hydrochloride — 21 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214651
Marketing start: Aug 9, 2021
Listing expires: Dec 31, 2026
Other FDA classes: NMDA Receptor Antagonists (Mechanism)
Identifiers: Product ID 59651-406_7a208302-90f3-45d0-94fc-9fb38591c543SPL ID 7a208302-90f3-45d0-94fc-9fb38591c543SPL set ID 2b2dcd54-47e0-494b-85d2-c28c3adbe737RxCUI 996594, 996603, 996609, 996615, 996624UNII JY0WD0UA60UPC 0359651406304, 0359651404300
Pharmacologic class: N-methyl-D-aspartate Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651040630 followed by a unit qualifier and the quantity

Package 59651-0406-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 5, 2022.

Indications (excerpt from the label)

Memantine hydrochloride extended-release capsules are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine hydrochloride is a N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214651

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214651
Product	Strength	Form · route	Labeler	Product NDC
Memantine Hydrochloride	Memantine hydrochloride 7 mg/1	Capsule, Extended releaseOral	Aurobindo Pharma Limited	59651-404
Memantine Hydrochloride	Memantine hydrochloride 14 mg/1	Capsule, Extended releaseOral	Aurobindo Pharma Limited	59651-405
Memantine Hydrochloride	Memantine hydrochloride 28 mg/1	Capsule, Extended releaseOral	Aurobindo Pharma Limited	59651-407
Memantine Hydrochloride	—	Kit	Aurobindo Pharma Limited	59651-408
Memantine Hydrochloride	Memantine hydrochloride 28 mg/1	Capsule, Extended releaseOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8662